Literature DB >> 9049200

Localization of thrombospondin in hepatocellular carcinoma.

K Hayashi1, T Kurohiji, K Shirouzu.   

Abstract

The expression of thrombospondin (TSP) of hepatocellular carcinoma (HCC) was investigated by light and electron microscopic immunohistochemical studies, using an anti-human TSP antibody to HCC and liver specimens. Tissue specimens were obtained by surgical resection from 60 patients with HCC. In light microscopic immunohistochemistry, all specimens showed strong immunoreaction for TSP in fibrous tissues in HCC and surrounding nonmalignant areas. In the strong TSP-stained fibrous tissue, immunoreaction for TSP was observed in fibroblasts and vascular endothelial cells. In 31 of 60 cases, HCC cells revealed cytoplasmic staining for TSP. In electron microscopic immunohistochemistry, reaction products for TSP were revealed in the rough endoplasmic reticulum (RER) of HCC cells, and also in the RER of fibroblasts and endothelial cells. These findings proved that TSP was synthesized in HCC cells, in endothelial cells, and in fibroblasts surrounding the tumor, and further suggested that TSP in the fibrous tissues surrounding carcinoma was basically synthesized by nonparenchymal cells such as fibroblasts and endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049200     DOI: 10.1002/hep.510250313

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells.

Authors:  K Breitkopf; I Sawitza; J H Westhoff; L Wickert; S Dooley; A M Gressner
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

2.  Expression of thrombospondin-1 in human hepatocarcinoma cell lines and its regulation by transcription factor Jun/AP-1.

Authors:  S A Kim; S J Um; J H Kang; K J Hong
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

Review 3.  Role of thrombospondin 1 in liver diseases.

Authors:  Yanzhang Li; Courtney P Turpin; Shuxia Wang
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

4.  Thrombospondin-1 expression correlates with angiogenesis in experimental cirrhosis.

Authors:  Gulsum-Ozlem Elpek; Guzide-Ayse Gokhan; Sevgi Bozova
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

5.  The CD47-binding peptide of thrombospondin-1 induces defenestration of liver sinusoidal endothelial cells.

Authors:  Lakshmi Venkatraman; Lisa Tucker-Kellogg
Journal:  Liver Int       Date:  2013-06-26       Impact factor: 5.828

6.  Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability.

Authors:  Tobias G Schips; Davy Vanhoutte; Alexander Vo; Robert N Correll; Matthew J Brody; Hadi Khalil; Jason Karch; Andoria Tjondrokoesoemo; Michelle A Sargent; Marjorie Maillet; Robert S Ross; Jeffery D Molkentin
Journal:  Nat Commun       Date:  2019-01-08       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.